Vimarsana
Biggest News Aggregation in the World

Page 3 - Number Needed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Number Needed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Number Needed Today - Breaking & Trending Today

Should you get a fourth COVID-19 shot? Here's what UCSF's Dr. Bob Wachter thinks - Vimarsana News

Should you get a fourth COVID-19 shot? Here's what UCSF's Dr. Bob Wachter thinks

Some countries are beginning to offer a second booster shot of the Pfizer or Moderna...

New Year's Resolution 15: Pluck it and see - Vimarsana News

New Year's Resolution 15: Pluck it and see

It’s that time of the year when we try to improve ourselves with resolutions to be better. Dr Chris Luke starts his regular column for IMT with a plan for

Source: imt.ie
Antipsychotics Even Riskier For The Elderly Than Previously Thought - Vimarsana News

Antipsychotics Even Riskier For The Elderly Than Previously Thought

Antipsychotic medications that are commonly being used to help control behaviors in elderly people with dementia seem to be causing premature deaths at high rates.

Researcher Critiques Misleading Claims About Antidepressant Effectiveness - Vimarsana News

Researcher Critiques Misleading Claims About Antidepressant Effectiveness

Recent claims about antidepressant effectiveness have been based on misleading statements and misunderstandings of the science.

vasopharm GmbH Announces Results of the NOSTRA III Traumatic Brain Injury Phase III Study - Vimarsana News

vasopharm GmbH Announces Results of the NOSTRA III Traumatic Brain Injury Phase III Study

vasopharm GmbH Announces Results of the NOSTRA III Traumatic Brain Injury Phase III Study - Post-hoc analysis reveals clinically meaningful and statistically significant improvement in eGOS when Ronopterin is infused within 12 hours after trauma - But over the entire patient population trial did not meet its primary endpoint - vasopharm will communicate next steps after discussing these results with Competent Authorities - Further results to be published in a peer-reviewed journal - Currently there are no approved treatments for patients with moderate and severe traumatic brain injury News pr...